Gene · 353
Papers3,627
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,627
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Assessing the cardiac autonomic response to bicycle exercise in Olympic athletes with different loads of endurance training: new insights from statistical indicators based on multilevel exploratory factor analysis. | Front Physiol | 2023 | 37916219 | PubTator, text mining | PubMed |
| Systems-level analyses dissociate genetic regulators of reactive oxygen species and energy production. | bioRxiv | 2023 | 37904938 | PubTator, text mining | PubMed |
| Ultrasound evaluation of diaphragmatic function in patients with idiopathic pulmonary fibrosis: a retrospective observational study. | Respir Res | 2023 | 37898765 | PubTator, text mining | PubMed |
| Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease. | Nutrients | 2023 | 37892555 | PubTator, text mining | PubMed |
| FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report. | J Immunother Cancer | 2023 | 37890888 | PubTator, text mining | PubMed |
| Purine metabolism-related genes and immunization in thyroid eye disease were validated using bioinformatics and machine learning. | Sci Rep | 2023 | 37884559 | PubTator, text mining | PubMed |
| CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications. | Iran Biomed J | 2023 | 37873636 | PubTator, text mining | PubMed |
| Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis. | Open Life Sci | 2023 | 37872967 | PubTator, text mining | PubMed |
| Rapid growth rate responses of terrestrial bacteria to field warming on the Antarctic Peninsula. | ISME J | 2023 | 37872274 | PubTator, text mining | PubMed |
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome. | Front Psychiatry | 2023 | 37854446 | PubTator, text mining | PubMed |
| Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1. | Genome Med | 2023 | 37848928 | PubTator, text mining | PubMed |
| The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations. | Leukemia | 2023 | 37845284 | PubTator, text mining | PubMed |
| Role of Antimicrobial Peptides in Immunity of Parasitic Leeches. | Dokl Biol Sci | 2023 | 37833572 | PubTator, text mining | PubMed |
| PTBP2 attenuation facilitates fibroblast to neuron conversion by promoting alternative splicing of neuronal genes. | Stem Cell Reports | 2023 | 37832540 | PubTator, text mining | PubMed |
| The evolution of antimicrobial peptides in Chiroptera. | Front Immunol | 2023 | 37822944 | PubTator, text mining | PubMed |
| The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death. | NPJ Genom Med | 2023 | 37821546 | PubTator, text mining | PubMed |
| Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes. | BJUI Compass | 2023 | 37818031 | PubTator, text mining | PubMed |
| Ferroptosis, autophagy, tumor and immunity. | Heliyon | 2023 | 37810047 | PubTator, text mining | PubMed |
| Restoring natural upper limb movement through a wrist prosthetic module for partial hand amputees. | J Neuroeng Rehabil | 2023 | 37798778 | PubTator, text mining | PubMed |
| Controlling piezoresistance in single molecules through the isomerisation of bullvalenes. | Nat Commun | 2023 | 37789027 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/353/papers?page=9